Finance News – Drug Trial
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Tariffs
Stocks
Investors
Shares
Crypto Assets
Stock
Cryptocurrency
Stock Market
Ethereum
Price
Markets
Xrp
Investment
Stablecoin
Blockchain
Etf
Sec
Eth
Bse
Ipo
Trade
Index
Solana
Earnings
Revenue
Inflation
Coinbase
China
Interest Rates
Token
Wall Street
Nasdaq
Sensex
Gold
Federal Reserve
Traders
Treasury
Nse
Usd
Economy
Bse Sensex
Trade War
Profit
Tesla
Digital Assets
Nifty
Fpi
Cobalt
Accountants
Losing Streak
Government Measures
Nikkei Index
Price Gains
Domestic Inflation Data
Gold Royalty
Market Slowdown
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Investopedia • Jun 18, 2025
Scholar Rock Stock Soars on Biopharma Firm's Weight-Loss Drug Trial Results
The recent clinical trial outcomes for a new weight management medication have led to a substantial increase in the market value of Scholar Rock, highlighting investor optimism in...
Read Full Article →
Investopedia • Jun 10, 2025
Insmed Stock Soars on Pulmonary Arterial Hypertension Drug Trial Results
Positive clinical trial outcomes for a new treatment targeting pulmonary arterial hypertension have led to a substantial increase in the company’s market valuation and investor int...
Read Full Article →